Resource Center

“The greatest enemy of knowledge is not ignorance, it is the illusion of knowledge”

Daniel J. Boorstin

Resource Center

“The greatest enemy of knowledge is not ignorance, it is the
illusion of knowledge”

Daniel J. Boorstin

Lorem ipsum dolor sit amet, consectetur adipiscing elit congue velit metus

Our content is created and provided by Physicians and our fellows who are medical students motivated to contribute their knowledge to this great community, generating valuable and top quality content to be an absolute reference for reliable information throughout the web.

Learn more about Glioblastoma and other diseases and stay updated about all the advances in these fields, you will not only find high-quality information but you will also be part of our community of people motivated to help all those affected directly or indirectly by these terrible sufferings

Glioblastoma map points to new protein targets and immuno-oncology approaches

There has been little progress in the search for cures for the aggressive brain cancer glioblastoma, largely because of a lack of understanding of how the tumor cells interact with the immune system and other cells and tissues in the body. A new glioblastoma map was designed to fill in some of those knowledge gaps.

Regulation of tumor immune suppression and cancer cell survival by CXCL1/2 elevation in glioblastoma multiforme

The invasiveness and high immune suppression of glioblastoma multiforme (GBM) produce poor survival of afflicted patients. Unfortunately, in the past decades, no therapeutic approach has remarkably improved the survival time of patients with GBM.

First Glioblastoma Patient Dosed in Phase 2 Trial Testing PVSRIPO Plus Keytruda

The first patient has been dosed in a Phase 2 trial assessing the safety and preliminary efficacy of PVSRIPO in combination with Keytruda (pembrolizumab) as a treatment for people with recurrent glioblastoma multiforme (rGBM), an aggressive form of brain cancer.

February 2021 Issue: “Gene and Viral Therapy for Glioblastoma Multiforme”

The February issue of Neurosurgical Focus examines the use of viral vector–mediated gene therapy in the treatment of glioblastoma multiforme (GBM).

FDA grants fast track designation to GLR2007 for glioblastoma

The FDA granted fast track designation to GLR2007 for treatment of glioblastoma, according to the agent’s manufacturer.

Breakthrough Science to Treat Colon Cancer and Glioblastoma

Breakthrough Science to Treat Colon Cancer and Glioblastoma was presented via Hidden GEMS Program from One Million Solutions in Health